Rationale and Therapeutic Opportunities for Natriuretic Peptide System Augmentation in Heart Failure

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

The natriuretic peptide system (NPS) is intimately involved in cardiorenal homeostasis in health, and dysregulation of the NPS plays an important role in the pathophysiology of heart failure (HF). Indeed, the diuretic, vasorelaxation, beneficial remodeling, and potent neurohumoral inhibition of the NPS support the therapeutic development of chronic augmentation of the NPS in symptomatic HF. Further, chronic augmentation of the protective NPS and in early stages of HF may ultimately prevent the progression of HF and reduced subsequent morbidity and mortality. In the current manuscript, we review the rationale for as well as previous and current efforts aimed at chronic therapeutic augmentation of the NPS in HF.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalCurrent Heart Failure Reports
Volume12
Issue number1
DOIs
StatePublished - 2015

Keywords

  • Cyclic guanosine monophosphate (cGMP)
  • Heart failure
  • Natriuretic peptide
  • Neprilysin
  • Neutral endopeptidase
  • Preclinical

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Emergency Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Rationale and Therapeutic Opportunities for Natriuretic Peptide System Augmentation in Heart Failure'. Together they form a unique fingerprint.

  • Cite this